A/s Genmab, 10% Owner at Merus N.V. (MRUS), bought 278,441 shares at $97.00 ($27.0M) on 2025-12-18, disclosed to the SEC on 2025-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.00 | 212,177 | $20.6M | 76.2% |
| 2 | $97.00 | 66,264 | $6.4M | 23.8% |
| Total | $97.00 avg | 278,441 | $27.0M | 100% |
| Filing → |
| MRUS | BUY | 2025-12-18 | $26.3M | — | Filing → |